This article is more than 5 years old. Information may no longer be current.
Integra LifeSciences receives 510k clearance for reverse shoulder system
Click Here to Manage Email Alerts
Integra LifeSciences Holdings Corporation announced that it has received 510k clearance for its Integra Titan Reverse Shoulder System.
The Reverse Shoulder System is built on a platform stem that simplifies the conversion of a primary total shoulder, or hemi for fracture, to a reverse shoulder, without the need to remove a stem that is well-fixed in the patient’s bone. According to a company press release, the system offers fully interchangeable components, which allow all primary, reverse and fracture humeral bodies to be used with either the press-fit or cemented platform stems. This flexibility provides surgeons with minimally invasive intraoperative options, and the ability to offer continued care for the lifetime of the patient.
“The Reverse Shoulder System is an exciting addition to Integra’s shoulder portfolio, which includes the Total Shoulder System and the Humeral Resurfacing Arthroplasty System,” Robert Paltridge, president of Integra, Extremity Reconstruction, stated.